Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics

W Liu, L Li, J Jiang, M Wu, P Lin - Precision clinical medicine, 2021 - academic.oup.com
Clustered regularly interspaced short palindromic repeats (CRISPR)-associated systems
(Cas) are efficient tools for targeting specific genes for laboratory research, agricultural …

RNA interference-based therapy and its delivery systems

X Chen, LS Mangala, C Rodriguez-Aguayo… - Cancer and Metastasis …, 2018 - Springer
RNA interference (RNAi) is considered a highly specific approach for gene silencing and
holds tremendous potential for treatment of various pathologic conditions such as …

Polydopamine-coated nucleic acid nanogel for siRNA-mediated low-temperature photothermal therapy

F Ding, X Gao, X Huang, H Ge, M **e, J Qian, J Song… - Biomaterials, 2020 - Elsevier
Photothermal therapy (PTT) normally requires to maintain the temperature of tumor lesions
above 50° C, which potentially induces local inflammation and tumor metastasis. To avoid …

Global profiling of lysine reactivity and ligandability in the human proteome

SM Hacker, KM Backus, MR Lazear, S Forli… - Nature …, 2017 - nature.com
Nucleophilic amino acids make important contributions to protein function, including
performing key roles in catalysis and serving as sites for post-translational modification …

The promise and peril of chemical probes

CH Arrowsmith, JE Audia, C Austin, J Baell… - Nature chemical …, 2015 - nature.com
Chemical probes are powerful reagents with increasing impacts on biomedical research.
However, probes of poor quality or that are used incorrectly generate misleading results. To …

Ligand and target discovery by fragment-based screening in human cells

CG Parker, A Galmozzi, Y Wang, BE Correia, K Sasaki… - Cell, 2017 - cell.com
Advances in the synthesis and screening of small-molecule libraries have accelerated the
discovery of chemical probes for studying biological processes. Still, only a small fraction of …

Recent advances in nanoparticle-based cancer drug and gene delivery

N Amreddy, A Babu, R Muralidharan… - Advances in cancer …, 2018 - Elsevier
Effective and safe delivery of anticancer agents is among the major challenges in cancer
therapy. The majority of anticancer agents are toxic to normal cells, have poor bioavailability …

Aurora A Kinase Inhibition Is Synthetic Lethal with Loss of the RB1 Tumor Suppressor Gene

X Gong, J Du, SH Parsons, FF Merzoug… - Cancer …, 2019 - aacrjournals.org
Loss-of-function mutations in the retinoblastoma gene RB1 are common in several treatment-
refractory cancers such as small-cell lung cancer and triple-negative breast cancer. To …

A SIRT2-selective inhibitor promotes c-Myc oncoprotein degradation and exhibits broad anticancer activity

H **g, J Hu, B He, YLN Abril, J Stupinski, K Weiser… - Cancer cell, 2016 - cell.com
Targeting sirtuins for cancer treatment has been a topic of debate due to conflicting reports
and lack of potent and specific inhibitors. We have developed a thiomyristoyl lysine …

The era of high-quality chemical probes

MP Licciardello, P Workman - RSC Medicinal Chemistry, 2022 - pubs.rsc.org
Small-molecule chemical probes are among the most important tools to study the function of
proteins in cells and organisms. Regrettably, the use of weak and non-selective small …